Combining low-dose cyclophosphamide with GM-CSFsecreting prostate cancer immunotherapy enhances antitumor immune effects

Emmanuel S. Antonarakis, Michael A. Carducci

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)311-314
Number of pages4
JournalExpert Opinion on Investigational Drugs
Volume19
Issue number2
DOIs
StatePublished - Feb 2010
Externally publishedYes

Keywords

  • Antitumor immunity
  • Cyclophosphamide
  • GVAX®
  • Immunotherapy
  • Prostate cancer

Cite this